QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 paypal-is-a-buy-jim-cramer-says-as-for-rivian-let-it-percolate

PayPal will become an additional credit and debit card processor for Shopify Payments through its PayPal Complete Payments solu...

 unitedhealth-follows-competitors-replaces-humira-with-lower-cost-biosimilars

UnitedHealth will remove AbbVie's Humira from its preferred drug lists by 2025, opting for lower-cost biosimilars like Amge...

 cvs-shares-are-trading-lower-wednesday-what-you-need-to-know

CVS Health Corporation (NYSE: CVS) shares are seeing a The sell-off comes in the wake of the recent Trump-Harris debate, which ...

 teva-announces-80m-settlement-to-baltimore-city-continues-opioid-litigation-against-other-companies

Baltimore secures an $80 million settlement with Teva Pharmaceuticals in its opioid crisis litigation. Funds will be allocated ...

 cantor-fitzgerald-reiterates-neutral-on-cvs-health-maintains-62-price-target

Cantor Fitzgerald analyst Sarah James reiterates CVS Health (NYSE:CVS) with a Neutral and maintains $62 price target.

 rbc-capital-reiterates-outperform-on-cvs-health-maintains-68-price-target

RBC Capital analyst Ben Hendrix reiterates CVS Health (NYSE:CVS) with a Outperform and maintains $68 price target.

 auto-stocks-abortion-health-care-in-spotlight-at-dnc-joe-biden-uaw-president-women-affected-by-roe-v-wade-decision-headline-night-1

The first night of the Democratic National Convention (DNC) could have investors eyeing sectors like healthcare and automotive ...

 cantor-fitzgerald-reiterates-neutral-on-cvs-health-maintains-62-price-target

Cantor Fitzgerald analyst Sarah James reiterates CVS Health (NYSE:CVS) with a Neutral and maintains $62 price target.

 pharmacy-chains-like-cvs-health-walgreens-boots-alliance-confront-shifting-consumer-habits-and-profit-pressures

Walgreens and CVS face declining profits as falling reimbursement rates, rising costs, and competition challenge the retail pha...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION